From evidence to action: optimising metabolic dysfunction-associated steatotic liver disease (MASLD) management in pharmacy practice
08 May 2026
Technical Services Theatre
Approximately 1 in 5 patients in the UK are currently living with metabolic-dysfunction associated liver disease (MASLD). This presentation will equip pharmacy professionals with the knowledge to identify and manage MASLD in primary and secondary care.

